93
Participants
Start Date
September 21, 2011
Primary Completion Date
October 31, 2016
Study Completion Date
February 10, 2017
GVAX Pancreas
CRS-207
Cyclophosphamide
NYU Langone Medical Center, New York
Herbert Irving Comprehensive Cancer Center of Columbia University, New York
University of Pittsburgh Medical Center, Pittsburgh
National Cancer Institute, Bethesda
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore
Duke University Medical Center, Durham
H. Lee Moffitt Cancer Center, Tampa
Washington University School of Medicine, St Louis
Providence Portland Medical Center, Portland
Virginia Mason Medical Center, Seattle
Lead Sponsor
Johns Hopkins University
OTHER
Aduro Biotech, Inc.
INDUSTRY